Jefferies Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
UBS Raises Price Target on Zimmer Biomet Holdings (ZBH) Following 2Q Earnings Report
August 2, 2016 9:18 AM EDTUBS reiterated a Neutral rating on Zimmer Biomet (NYSE: ZBH), and raised the price target to $132.00 (from $117.00), following the company's 2Q earnings report.
Analyst Matt Miksic commented, "WW sales growth improved in Q2 for most business lines, partially driven by extra selling days (+1.9% WW), and Zimmer Biomet narrowed its gap in... More
Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 5c; Boosts FY16 Outlook
July 28, 2016 7:39 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.02, $0.05 better than the analyst estimate of $1.97. Revenue for the quarter came in at $1.93 billion versus the consensus estimate of $1.9 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2016 EPS of $7.90-$8.00, versus prior... More
Trading Radar for 7/28: Alphabet (GOOG), Amazon (AMZN), Ford (F), Baidu (BIDU), MasterCard (MA) Report
July 27, 2016 2:49 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus loss $0.04
ARIAD Pharma (Nasdaq: ARIA) - consensus loss $0.11
Acorda Therapeutics (Nasdaq: ACOR) - consensus EPS $0.18
Agenus (Nasdaq: AGEN) - consensus... More
